[Remote] Associate Director, Sales Training and Development at Acadia Pharmaceuticals

Remote

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Skills

Key technologies and capabilities for this role

Sales TrainingCurriculum DevelopmentNew Hire TrainingProduct Launch TrainingAccount-Based SellingHospital SellingCustomer-Centric SellingLeadership CoachingSales StrategyField ExecutionCompetency-Based LearningTraining EvaluationVendor ManagementRegulatory ComplianceMedical ComplianceMarketing Alignment

Questions & Answers

Common questions about this position

What experience is required for the Associate Director, Sales Training and Development role?

Candidates need 8–10 years of successful pharmaceutical sales experience (hospital experience strongly preferred), recent experience in antibiotic or infectious disease sales preferred, and 4+ years of corporate training or home office experience preferred.

What key skills are needed for this position?

Required skills include high clinical acumen in infectious diseases, excellent facilitation and communication skills, strong project management, and the ability to manage multiple projects in a fast-paced environment.

What is the company culture like for this role?

The role emphasizes emulating core values of Resourceful, Collaborative, Passionate, Purposeful, and building a high-performance culture grounded in excellence, innovation, and continuous improvement.

What education is required for this position?

A Bachelor's degree is required.

What makes a strong candidate for this role?

A strong candidate has pharmaceutical sales experience in hospitals or infectious diseases, training expertise, clinical acumen, and skills in facilitation, project management, and cross-functional collaboration.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI